Ultralife ( (ULBI) ) has released a notification of late filing.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Ultralife Corporation has announced a delay in filing its Form 10-Q (Quarter Report) for the financial period ending September 30, 2025. The delay is primarily due to the recent transition of Electrochem Solutions, Inc.’s financial systems to Ultralife’s systems following its acquisition from Integer Holdings Corporation. This transition necessitated additional time to finalize third-quarter results and complete the review by independent accountants. The company anticipates filing the report by November 17, 2025, within the five-day extension period allowed. Ultralife does not expect any significant changes in financial results compared to the previous year. The notification was signed by Philip A. Fain, Chief Financial Officer & Treasurer, indicating ongoing compliance efforts.
The most recent analyst rating on (ULBI) stock is a Hold with a $7.50 price target. To see the full list of analyst forecasts on Ultralife stock, see the ULBI Stock Forecast page.
Spark’s Take on ULBI Stock
According to Spark, TipRanks’ AI Analyst, ULBI is a Neutral.
Ultralife’s overall stock score reflects a stable financial position with strong balance sheet metrics but challenges in profitability and cash flow. Technical analysis indicates mixed signals, with short-term stability but potential medium-term weakness. The stock appears overvalued, and while the earnings call showed optimism for future growth, current operational challenges remain significant.
To see Spark’s full report on ULBI stock, click here.
More about Ultralife
Average Trading Volume: 52,559
Technical Sentiment Signal: Sell
Current Market Cap: $116.7M
Find detailed analytics on ULBI stock on TipRanks’ Stock Analysis page.